Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate

Star0

DB03891ExperimentalSmall molecule

Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate: Overview.

Formula / weight: C₂₉H₄₀N₆O₇ · 584.6639 g/mol (avg)
Also known as: 1,5-Bis(N-benzyloxycarbonyl-L-leucinyl)carbohydrazide

Resolves to

Compound

ChEMBLCHEMBL115357PubChem5288634

Structure

InChIKeyHGDUWJVGIGLVOH-ZEQRLZLVSA-NSMILES[H]N(N([H])C(=O)[C@H](CC(C)C)N([H])C(=O)OCC1=CC=CC=C1)C(=O)N([H])N([H])C(=O)[C@H](CC(C)C)N([H])C(=O)OCC1=CC=CC=C1

Targets

P43235CTSK

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account